Abstract: A method for forming a semiconductor device structure is provided. The method includes forming a first metal layer over a substrate, forming a dielectric layer over the first metal layer. The method includes forming a trench in the dielectric layer, and performing a surface treatment process on a sidewall surface of the trench to form a hydrophobic layer. The hydrophobic layer is formed on a sidewall surface of the dielectric layer. The method further includes depositing a metal material in the trench and over the hydrophobic layer to form a via structure.

Abstract: The present disclosure relates to a seismic imaging free gas structure identification method and system, The method includes: acquiring a seismic imaging dataset, and annotating free gas structures in the seismic imaging sample data set to obtain a training dataset; using a generative adversarial network (GAN) to expand the training dataset for network training, wherein the GAN includes a generative network and a discrimination network; conducting domain conversion on original label data of the free gas training samples to obtain annotating labels: training a Bayesian neural network according to the free gas training datasets and labels, to obtain a free gas structure identification model; acquiring actual seismic imaging data of a target work area; and conducting, according to the actual seismic imaging data, identification by using the free gas structure identification model.

Abstract: The present disclosure provides a vehicle positioning device for vehicle vision calibration, a positioning adjustment method, and a positioning adjustment system. The vehicle positioning device includes a base, a chassis, a translation mechanism and a rotation mechanism. A to-be-calibrated vehicle is placed onto the chassis, and the chassis is provided with a stopper. The translation mechanism is arranged between the chassis and the base, and configured to drive the chassis to move in an X-axis direction in a three-dimensional coordinate system relative to the base in accordance with a translation control instruction. The rotation mechanism is arranged between the chassis and the base, and configured to drive the chassis to rotate about a Z-axis in the three-dimensional coordinate system relative to the base in accordance with a rotation control instruction.

Abstract: A stable anti-TIGIT antibody pharmaceutical composition and an application thereof. The pharmaceutical composition includes a buffer solution, and an anti-TIGIT antibody or an antigen-binding fragment thereof. The anti-TIGIT antibody or the antigen-binding fragment thereof includes HCDR1, HCDR2, and HCDR3 having amino acid sequences as respectively represented by SEQ ID NO:1, SEQ ID NO:2, and SEQ ID NO:3, and LCDR1, LCDR2, and LCDR3 having amino acid sequences as respectively represented by SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6. The pH of the pharmaceutical composition is about 5.0-6.5.

Abstract: An electrochemical device, including a cathode, an anode and an electrolyte. The anode includes an anode current collector and an anode active material disposed on the anode current collector, the electrolyte includes fluoroethylene carbonate, and the electrochemical device meets the following relationship: 17.55?K1?K2?1.63K32+11.27K3?20.80, where K1 represents a specific surface area value of the unit mass of the anode active material (in m2/g), and 1.0?K1?2.0; K2 represents a content value of the fluoroethylene carbonate required by per Ah capacity (in g/Ah), and 0.05?K2?0.25; and K3 represents a weight value of the anode active material required by per Ah capacity (in g/Ah).

Abstract: Provided is an elliptical multi-mesa laser structure, including a substrate layer, an N-DBR, a functional layer and a P-DBR sequentially arranged from bottom to top. The substrate layer is fixedly connected with an N contact layer. The N-DBR is fixedly connected to a top of the substrate layer, and the N contact layer is arranged around the N-DBR. A space layer is inserted in the N-DBR. The functional layer is fixedly connected to a top of the N-DBR. The P-DBR is fixedly connected to a top of the functional layer, and a top of the P-DBR is fixedly connected with a P contact layer. Another space layer is inserted into the P-DBR.

Abstract: Disclosed are a continuous rolling device and method with interfacial temperature-force controllability for a seamless metal cladding pipe. The device comprises a multi-roller skew rolling mill set, an interfacial temperature-force controlled rolling mill set and a sizing and finishing mill set sequentially distributed along a rolling axis; and the interfacial temperature-force controlled rolling mill set comprises an interface temperature control module and an interface pressure control module sequentially distributed along the rolling axis, the interface pressure control module comprises two racks and a plurality of controlled rolling rollers circumferentially and evenly distributed along the rolling axis, two ends of the controlled rolling roller are respectively mounted on the two racks through corresponding screwdown apparatuses, and the interface pressure control module realizes passive driving through a spiral pushing force or a traction force.

Abstract: The present disclosure relates, according to some embodiments, to photostable photoactive compositions comprising (a) at least one photoactive compound that develops within itself an excited state energy when subjected to UV radiation and (b) a block copolymer comprising a plurality of blocks, wherein the block copolymer is operable to quench the excited state energy.

Abstract: The present invention relates to the use of an anti-PD-1 antibody or an antigen-binding fragment thereof in preparing a drug for preventing or treating a malignant cancer, and the use of a combination of an anti-PD-1 antibody or an antigen-binding fragment thereof and gemcitabine-cisplatin in preparing a drug for preventing or treating a malignant cancer. The malignant cancer is preferably nasopharyngeal carcinoma. The present invention also relates to a method for using a biomarker to predict the therapeutic effect of the anti-PD-1 antibody or the antigen-binding fragment thereof in treatment of nasopharyngeal carcinoma.

Abstract: A stability control method and device based on particle active disturbance rejection are provided. The method includes: establishing an active disturbance rejection controller model based on a dynamic model and a speed loop control model of a tethered balloon system, where the speed loop control model is established through theoretical modeling of executive components of a control system of the tethered balloon system; and optimizing to-be-optimized parameters of the active disturbance rejection controller model using a particle swarm optimization algorithm, determining an optimal active disturbance rejection controller model, and using the optimal active disturbance rejection controller model to implement stability control of a photoelectric pod. An active disturbance rejection controller is optimized by using a particle swarm optimization algorithm, which can effectively isolate the internal and external disturbances of the photoelectric pod and improve the imaging stability of the photoelectric pod.

Abstract: The invention provides a method for designing a diffractive optical element, characterized in comprising: S101: obtaining a first optical field pattern on a target plane; S102: converting the first optical field pattern on the target plane into a second optical field pattern on a spherical surface; S103: compensating for missing points of the second optical field pattern on the spherical surface, and matching grayscale values, so as to obtain a corrected third optical field pattern; and S104: obtaining a phase distribution of the diffractive optical element according to the third optical field pattern. By means of the design method, the projection quality of a diffractive optical element is improved.

Abstract: The present disclosure relates to the use of an anti-BTLA antagonist (including antibodies and antigen binding fragments) in the treatment of various tumors, either as a mono therapy or a combination therapy with other immune checkpoint inhibitor therapy such as anti-PD-1 or anti-PD-L1, and methods of selecting subjects in need of treatment. Preferably, various solid tumors are treated.

Abstract: Provided are a combination of an anti-PD-1 antibody or an antigen binding fragment of the anti-PD-1 antibody and a cytotoxic anticancer drug, and the use of the combination in the preparation of a medicine for treating non-small cell lung cancer. Specifically, Provided are a combination of an anti-PD-1 antibody or an antigen-binding fragment of the anti-PD-1 antibody, an anti-folate metabolism anticancer drug, and a platinum anticancer drug, and the use of the combination in the preparation of a medicine for treating non-small cell lung cancer that has failed EGFR-TKI treatment.

Abstract: An image processing method, for processing image data to be displayed by a display panel having a display area being divided into multiple sub-areas, including: determining a power-saving ratio for each sub-area according to a power-saving level; and sequentially adjusting image data of each sub-area in the original image data according to the power-saving ratio corresponding to said sub-area to generate output image data. In the output image data, a characteristic value of the image data corresponding to one of the sub-areas is reduced.

Abstract: The present disclosure relates, according to some embodiments, to photostable photoactive compositions comprising (a) at least one photoactive compound that develops within itself an excited state energy when subjected to UV radiation and (b) a block copolymer comprising a plurality of blocks, wherein the block copolymer is operable to quench the excited state energy.

Abstract: An antibody specifically binding to CTLA-4 or an antigen-binding fragment thereof, and a composition comprising same. Also provided are a nucleic acid molecule encoding the antibody or an antigen-binding fragment thereof, a vector and a host cell for expressing the antibody or an antigen-binding fragment thereof, and therapcutic and diagnostic methods and the use of the antibody or an antigen-binding fragment thereof.

Abstract: A stability control method and device based on particle active disturbance rejection are provided. The method includes: establishing an active disturbance rejection controller model based on a dynamic model and a speed loop control model of a tethered balloon system, where the speed loop control model is established through theoretical modeling of executive components of a control system of the tethered balloon system; and optimizing to-be-optimized parameters of the active disturbance rejection controller model using a particle swarm optimization algorithm, determining an optimal active disturbance rejection controller model, and using the optimal active disturbance rejection controller model to implement stability control of a photoelectric pod. An active disturbance rejection controller is optimized by using a particle swarm optimization algorithm, which can effectively isolate the internal and external disturbances of the photoelectric pod and improve the imaging stability of the photoelectric pod.

Abstract: The present disclosure relates to use of an anti-PD-1 antibody and/or an antigen-binding fragment thereof in the treatment of a neuroendocrine neoplasm. The present disclosure also relates to an agent or a kit for detecting an ARID1A gene mutation or amplification, or a chromosomal gene rearrangement, and use of the detection agent or kit in predicting the therapeutic effect of an anti-PD-1 antibody or an antigen-binding fragment thereof in the treatment of a patient with a neuroendocrine neoplasm.

Abstract: An example vehicle charging method includes: obtaining a status of a first battery pack in a first mobile charging facility; in response to determining that the first battery pack is in a charging state or a fully charged state, obtaining a second state of energy sent by a second mobile charging facility, where the second mobile charging facility is charging a first vehicle, and the second state of energy is a state of energy of a second battery pack in the second mobile charging facility; and in response to at least that a first state of energy and the second state of energy meet a first preset condition, sending a first indication signal to the first mobile charging facility for indicating the first mobile charging facility to charge the first vehicle.